/IMAX

Imax Corp

IMAX

$52.09USD↑+1.44%+0.74 today

MARKET CAP

2.9B

P/E (TTM)

80.1x

FWD P/E

—

DAY RANGE

$51 – $52

52W RANGE

$31

$56

AI Summary

Stalk

StalkMedium

IMAX remains in a Stage 2 advancing regime, trading above rising EMAs and SMAs. Price has consolidated sideways, holding near the mid-range of its recent advance and above the 50-day SMA. Short-term momentum is neutral with no clear timing edge, while medium-term bias stays bullish. The preferred approach is to stalk pullbacks into the rising EMA cluster around the 50-day SMA for an actionable entry.

↑FY25 revenue rose 40% YoY to $1.28B; adjusted EBITDA margin reached 45%.
↑The Odyssey opening weekend delivered $52M with 75% theater occupancy domestically.
↓Blockbuster dependence poses downside if major releases underperform.

Full analysis →

Buying

5

institutions

Selling

6

institutions

New Positions

1

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕	Action↕	Shares Held↕	Value↓	Change↕	Chg %↕	Weight↕
BI Blackrock, Inc. Q2 2026	BUY	2.91 M	115.88 M	+284.60 K	+16.3%	0.00%
JC Jpmorgan Chase & Co Q2 2026	BUY	1.45 M	58.79 M	+480.06 K	+61.3%	0.00%
JH Janus Henderson Group Plc Q1 2026	BUY	522.12 K	19.85 M	+284.72 K	+126.2%	0.00%
PA Point72 Asset Management, L.P. Q2 2026	SELL	440.00 K	17.54 M	+-160.00 K	-23.1%	0.02%
CA Citadel Advisors LLC Q2 2026	SELL	140.10 K	5.58 M	+-20.90 K	-8.8%	0.00%
RT Renaissance Technologies LLC Q2 2026	BUY	99.00 K	3.95 M	+24.90 K	+40.1%	0.01%
AC Aqr Capital Management LLC Q2 2026	SELL	46.27 K	1.84 M	+-202.00	+4.4%	0.00%
MG Man Group Plc Q2 2026	BUYNEW	23.85 K	950.50 K	+23.85 K	+0.0%	0.00%
RC Rockefeller Capital Management L.P. Q2 2026	SELL	180.00	7.17 K	+-10.00	-0.7%	0.00%
MM Millennium Management LLC Q2 2026	SELL	0.00	0.00	+-205.34 K	-100.0%	0.00%
BH Brevan Howard Capital Management LP Q2 2026	SELL	0.00	0.00	+-14.57 K	-100.0%	0.00%